BON
NASDAQBon Natural Life Limited
Bon Natural Life Limited (BON) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. There were no new wire items for BON in the last 30 days. The most recent was published Sep 23, 2026.
Financial highlights
Full financials- Revenue, FY2025
- $18.67M
- Revenue growth
- -21.7%
- Net income, FY2025
- -$1.99M
- Net margin
- -10.7%
- Free cash flow, FY2025
- $134.3K
- Cash
- $6.27M
For fiscal 2025 (ended Sep 30, 2025), from SEC filings. Not investment advice.
News · 26 weeks1-100%
2026-05-172026-11-08
Mix190d
- SEC Filings1(100%)
Activity · 52 weeks1811 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- INSIDERSEC Form 3 filed by new insider Zhixiang Gao3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Jing Veronica3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Hu Yongwei3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Xue Yingchun3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ma Xin3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wenjuan Chen3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liu Jing3 - Bon Natural Life Ltd (0001816815) (Issuer)
- INSIDERSEC Form 3 filed by new insider Gao Jianjun3 - Bon Natural Life Ltd (0001816815) (Issuer)
- PRBON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health InitiativesXI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tigerbone Group Limited ("Tigerbone Group"). As part of this strategic initiative, the parties also announced plans to establish the "BON Cooperation and Development Committee," which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths. Pursuant to the Agreement, an
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- PRBON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics MarketXI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful development of a premium anti-aging facial mask incorporating apple polyphenols as its core active ingredient and integrated with AI-enabled flexible bio-electronic technology. Leveraging advanced transdermal delivery systems, this product integrates plant-derived active ingredients with intelligent flexible electronics, creating a next-generation skin care solution designed to be non-invasive, painless, and suitable for at-home use. Serving as the core na
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- PRBON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturingXI'AN, China, Feb. 17, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing (the "Joint Laboratory"). The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the Company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Science Industry Innovation Center Co., Ltd. ("Chang'an Pilot"). The Joint Laboratory will focus on the research and development of bio-manufactured natural activ
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- PRBON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with QingshengyuanXI'AN, China, Dec. 10, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. ("Qingshengyuan"), a leading distributor of functional health products in China focusing on digestive and metabolic wellness. The two parties entered into a non-exclusive strategic sales agreement. The term of the agreement is 24 months with a total contract value of $12 million. Pursuant to the agreement, Qingshengyuan will sell and di
- PRBON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai KeyuanXI'AN, China, Nov. 25, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 36 months with a total contract value of US$26 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health products in Greater China. Tea pigments, a key bioactive complex derived from tea, possess a strong scientific profile
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- SECAmendment: SEC Form F-3/A filed by Bon Natural Life LimitedF-3/A - Bon Natural Life Ltd (0001816815) (Filer)
- SECSEC Form F-3 filed by Bon Natural Life LimitedF-3 - Bon Natural Life Ltd (0001816815) (Filer)
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- SECSEC Form 6-K filed by Bon Natural Life Limited6-K - Bon Natural Life Ltd (0001816815) (Filer)
- PRBON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health ProductsXI'AN, China, Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced it has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 24 months with a total contract value of US$18 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's innovative second-generation Apple Series health products across Greater China, tapping into significant market potential in the weight management and m
- PRBON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D PlatformXI'AN, China, Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current mainstream weight-managing drugs, injecting new momentum into global R&D of weight-managing drugs. With a worsening global obesity crisis, the weight-manag
BON FAQ
9 questionsWhat is the latest news on BON?
Quantisnow has not tracked any new filings, ratings or press releases for BON in the last 30 days. The most recent wire item was published on September 23, 2026.What is BON revenue?
Bon Natural Life Limited (BON) reported $18.67M of revenue for fiscal 2025 (ended Sep 30, 2025). That is down 21.7% from the year before.Is BON profitable?
No. Bon Natural Life Limited reported a net loss of $1.99M for fiscal 2025 (ended Sep 30, 2025).How much cash and debt does BON have?
Bon Natural Life Limited reported $6.27M in cash and cash equivalents and $1.92M of debt on its most recent balance sheet in SEC filings.Where does BON stock trade?
Bon Natural Life Limited (BON) is listed on NASDAQ.What sector and industry is BON in?
Bon Natural Life Limited operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Bon Natural Life Limited go public?
Bon Natural Life Limited (BON) completed its IPO in 2021.What companies are similar to BON?
Notable peers in the same industry include TRLV (Trulieve Cannabis Corp. Subordinate Voting Shares), DFTX (Definium Therapeutics Inc.), CRON (Cronos Group Inc.), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.). Compare BON side-by-side with any of them on Quantisnow.How can I track BON on Quantisnow?
Quantisnow aggregates Bon Natural Life Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BON to receive live email and push alerts on every new disclosure.